Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
The Peter Munk Cardiac Centre has received international recognition for its scientific contributions on the diagnosis and treatment of patients with aortic and mitral valve diseases. Diseases of the aortic and mitral valves are a leading cause of heart failure, yet the etiology and molecular mechanisms of these diseases are not well understood.
The PMCC is propelling research to bring together our world-renowned clinical program with experts in biomedical research at Toronto General Research Institute and the University of Toronto. This initiative will promote multidisciplinary care by teams of cardiac surgeons, cardiologists and medical imaging physicians to enable coordinated delivery of the most advanced therapies in the world. It will develop the basic and clinical research programs necessary to advance our understanding of heart valve pathologies, test new therapeutic modalities and investigate the genetic basis of these disorders. The synergies created will establish PMCC as a world authority in the clinical and basic science of heart valve diseases and this synergy will benefit thousands of patients in Canada and around the world.